Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake

Neuroscience Letters

Volumn 354, Issue 3, 2004, Pages 209-212

  Saldaña, Shannon N ^a   Barker, Eric L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Amphetamine; Biogenic amine; Ecstasy; Neurotoxicity; Psychostimulants; Reuptake

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; SEROTONIN TRANSPORTER;

ARTICLE; BODY TEMPERATURE; CELL LINE; CONTROLLED STUDY; DOPAMINE UPTAKE; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SEROTONIN UPTAKE; TEMPERATURE DEPENDENCE; TRANSPORT KINETICS;

EID: 0346422386     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.10.032     Document Type: Article

References (18)

1. Barker E.L., Perlman M.A., Adkins E.M., Houlihan W.J., Pristupa Z.B., Niznik H.B., Blakely R.D. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis - an aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J. Biol. Chem. 273:1998;19459-19468.
2. Blakely R.D., Clark J.A., Rudnick G., Amara S.G. Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. Anal. Biochem. 194:1991;302-308.
3. Buchert R., Obrocki J., Thomasius R., Vaterlein O., Petersen K., Jenicke L., Bohuslavizki K.H., Clausen M. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET. Nucl. Med. Commun. 22:2001;889-897.
4. Fleckenstein A.E., Haughey H.M., Metzger R.R., Kokoshka J.M., Riddle E.L., Hanson J.E., Gibb J.W., Hanson G.R. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur. J. Pharmacol. 382:1999;45-49.
5. Fuerst T.R., Niles E., Studier F.W., Moss B. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
6. Garris P.A., Ciolkowski E.L., Pastore P., Wightman R.M. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14:1994;6084-6093.
7. Gordon C.J., Watkinson W.P., O'Callaghan J.P., Miller D.B. Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol. Biochem. Behav. 38:1991;339-344.
8. Haughey H.M., Brown J.M., Fleckenstein A.E., Hanson G.R. Oxygen radicals differentially affect Na+/Cl(-)-dependent transporters. Eur. J. Pharmacol. 379:1999;107-110.
9. Malberg J.E., Malis R.W., Sabol K.E., Seiden L.S. Drugs that protect against MDMA-induced serotonin neurotoxicity have different effects on body temperature in the rat when administered in combination with MDMA. Neurosci. Abs. 20:1994;290.
10. O'Shea E., Esteban B., Camarero J., Green A.R., Colado M.I. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology. 40:2001;65-74.
11. Ramsey I.S., DeFelice L.J. Serotonin transporter function and pharmacology are sensitive to expression level - evidence for an endogenous regulatory factor. J. Biol. Chem. 277:2002;14475-14482.
12. Rudnick G., Wall S.C. The molecular mechanism of 'ecstasy' [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA. 89:1992;1817-1821.
13. Schmidt C.J., Levin J.A., Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36:1987;747-755.
14. Schmidt C.J., Lovenberg W. In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat. Neurosci. Lett. 59:1985;9-14.
15. Sonders M.S., Mortensen O.V., Porzgen P., Amara S.G. Identifying regulators of serotonin transporter function. Neurosci. Abs. 26:2000;1173.
16. Sprague J.E., Everman S.L., Nichols D.E. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology. 19:1998;427-441.
17. Sprague J.E., Johnson M.P., Schmidt C.J., Nichols D.E. Studies on the mechanism of p-chloroamphetamine neurotoxicity. Biochem. Pharmacol. 52:1996;1271-1277.
18. Sprague J.E., Nichols D.E. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J. Pharmacol. Exp. Ther. 273:1995;667-673.